Extracellular-signal-regulated kinase 5-ERK5 (a member of the MAPK family) is a master molecule which inhibits atherosclerosis either by interacting with various proteins to inhibit inflammatory pathways or by controlling the expression of various anti-atherogenic targets [35]. The gene discussed is MAPK7; the disease is atherosclerosis.